Medicine & Life Sciences
Cost-Benefit Analysis
100%
Belgium
83%
Costs and Cost Analysis
76%
Systematic Reviews
57%
Health
46%
Economics
34%
Pandemics
31%
Illicit Drugs
28%
Neonatal Screening
22%
Gestational Diabetes
21%
Quality-Adjusted Life Years
21%
Delivery of Health Care
19%
Cystic Fibrosis
19%
Workplace
18%
Reminder Systems
15%
Type 2 Diabetes Mellitus
14%
Cardiovascular Diseases
14%
Alcohols
13%
Evaluation Studies
12%
Coronavirus
12%
Sick Leave
11%
Sedentary Behavior
10%
Health Promotion
9%
Human Influenza
8%
Referral and Consultation
8%
Type 1 Diabetes Mellitus
8%
Tobacco
8%
Life Style
7%
Vaccination
7%
Mental Health
7%
Depression
7%
Occupational Groups
6%
Cohort Studies
6%
Uncertainty
6%
Exercise
6%
Myocardial Ischemia
6%
Prospective Studies
6%
Glucose
6%
DNA
5%
Cost of Illness
5%
Preventive Medicine
5%
Databases
5%
Law Enforcement
5%
Oral Health
5%
Social Sciences
Health Economics
54%
costs
54%
social costs
33%
Belgium
31%
evaluation
24%
life years
18%
utility analysis
15%
sick leave
13%
Healthcare
12%
alcohol
12%
cardiovascular disease
12%
vaccination
10%
chronic illness
9%
contagious disease
9%
health promotion
9%
drug
9%
health
8%
workplace
7%
economics
7%
economic impact
7%
employee
6%
mental health
6%
nicotine
6%
hospital admission
5%
adolescent
5%
pilot project
5%
heart disease
5%
preventive care
5%
literature
5%